TrialEuropean heart journal2018

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.

Javier Bermejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.